AF
NEO icon

Amalgamated Financial’s NeoGenomics NEO Stock Holding History

Amalgamated Financial’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$721K Buy
+59,354
New +$1.25M 0.01% 1348

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KFO
Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Amalgamated Financial's NEO Position: Q1 2022 in Review

Amalgamated Financial opened a new position in NeoGenomics (NEO) in Q1 2022: 59,354 shares worth $721K. The stake represents 0.01% of the portfolio and ranks #1348 among its holdings.

280 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Amalgamated Financial held 59,354 shares of NeoGenomics worth $721K as of Q1 2022.
  • NeoGenomics was a new Amalgamated Financial position in Q1 2022.
  • NeoGenomics made up 0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1348 holding.
  • 280 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.